Evidence map›Paper›PMID 22002537›Full record

ArticleThe EMBO journal2012

Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.

Nadine Martin, Moussa Benhamed, Karim Nacerddine, Maud D Demarque, Maarten van Lohuizen, Anne Dejean, Oliver Bischof

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biomedical reports · 2017
    Article
  7. Article
  8. Article
  9. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Nadine MartinDepartment of Cell Biology and Infection, Nuclear Organisation and Oncogenesis Laboratory, Institut Pasteur, Paris, France.
Moussa Benhamed
Karim Nacerddine
Maud D Demarque
Maarten van Lohuizen
Anne Dejean
Oliver Bischof
Institut Pasteur · FRCancer Genomics Centre · NLInserm · FRThe Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular senescence acts as a potent barrier for tumour initiation and progression. Previous studies showed that the PML tumour suppressor promotes senescence, although the precise mechanisms remain to be elucidated. Combining gene expression profiling with chromatin-binding analyses and promoter reporter studies, we identify TBX2, a T-box transcription factor frequently overexpressed in cancer, as a novel and direct PML-repressible E2F-target gene in senescence but not quiescence. Recruitment of PML to the TBX2 promoter is dependent on a functional p130/E2F4 repressor complex ultimately implementing a transcriptionally inactive chromatin environment at the TBX2 promoter. TBX2 repression actively contributes to senescence induction as cells depleted for TBX2 trigger PML pro-senescence function(s) and enter senescence. Reciprocally, elevated TBX2 levels antagonize PML pro-senescence function through direct protein-protein interaction. Collectively, our findings indicate that PML and TBX2 act in an autoregulatory loop to control the effective execution of the senescence program.

Indexed as

Cellular SenescenceAnimalsFibroblastsHumansMiceNIH 3T3 CellsNuclear ProteinsPromoter Regions, GeneticPromyelocytic Leukemia ProteinT-Box Domain ProteinsTranscription FactorsTumor Suppressor ProteinsNuclear ProteinsPml protein, mousePromyelocytic Leukemia ProteinT-Box Domain Protein 2T-Box Domain ProteinsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID22002537
PMCPMC3252579
OpenAlexW1950397895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.